Zhongxing Bio-Tech approves related transaction at shareholder meeting
Tianshui Zhongxing Bio-Technology Co., Ltd. announced the resolutions passed at its first extraordinary general meeting of shareholders held on July 7, 2025. The meeting saw participation from shareholders and authorized representatives holding a total of 153,344,258 shares, representing 40.9199% of the company's total voting shares as of the record date. Shareholders approved the "Proposal on Joint Investment with Related Parties and Related Transactions." The approval rate reached 99.2173% of the total votes cast. The involved related shareholders, holding 4,068,609 shares, abstained from voting on the proposal. Legal counsel confirmed the meeting's compliance with relevant laws and regulations.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Tianshui Zhongxing Bio-Technology publishes news
Free account required • Unsubscribe anytime